| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer
|
Sahin, Ugur
|
|
2018
|
100 |
C |
p. 17-26
|
artikel
|
| 2 |
Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group
|
Goey, Kaitlyn K.H.
|
|
2018
|
100 |
C |
p. 35-45
|
artikel
|
| 3 |
Corrigendum to ‘Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study’ [Eur J Canc 81 (2017) 17–25]
|
Chau, Ian
|
|
2018
|
100 |
C |
p. 135-136
|
artikel
|
| 4 |
Economic evaluation of an expert examiner and different ultrasound models in the diagnosis of ovarian cancer
|
Meys, Evelyne M.J.
|
|
2018
|
100 |
C |
p. 55-64
|
artikel
|
| 5 |
Mapping the European cancer research landscape: An evidence base for national and Pan-European research and funding
|
Begum, Mursheda
|
|
2018
|
100 |
C |
p. 75-84
|
artikel
|
| 6 |
Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: What survival can we expect?
|
Gelli, Maximiliano
|
|
2018
|
100 |
C |
p. 94-103
|
artikel
|
| 7 |
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer
|
Moreno, Lucas
|
|
2018
|
100 |
C |
p. 27-34
|
artikel
|
| 8 |
Predicting early death in older adults with cancer
|
Boulahssass, Rabia
|
|
2018
|
100 |
C |
p. 65-74
|
artikel
|
| 9 |
Safety and efficacy of Nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering from cholestatic hyperbilirubinaemia—A retrospective analysis
|
Pelzer, Uwe
|
|
2018
|
100 |
C |
p. 85-93
|
artikel
|
| 10 |
Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study
|
Sheng, Xinan
|
|
2018
|
100 |
C |
p. 1-7
|
artikel
|
| 11 |
The effect of age on outcomes after isolated limb perfusion for advanced extremity malignancies
|
Smith, H.G.
|
|
2018
|
100 |
C |
p. 46-54
|
artikel
|
| 12 |
The EORTC CAT Core—The computer adaptive version of the EORTC QLQ-C30 questionnaire
|
Petersen, Morten Aa.
|
|
2018
|
100 |
C |
p. 8-16
|
artikel
|
| 13 |
The level of reporting of neurocognitive outcomes in randomised controlled trials of brain tumour patients: A systematic review
|
Habets, Esther J.J.
|
|
2018
|
100 |
C |
p. 104-125
|
artikel
|
| 14 |
Use of nivolumab in elderly patients with advanced squamous non–small-cell lung cancer: results from the Italian cohort of an expanded access programme
|
Grossi, Francesco
|
|
2018
|
100 |
C |
p. 126-134
|
artikel
|
Tijdschrift beschrijving